Dr. Julian Magadan III, MD

Dr. Magadan practices at Kansas City Physician Partners Inc in Kansas City, Missouri.

Dr. Magadan's NPI, 1568660389, was assigned on July 3, 2007. Dr. Magadan graduated from UT Southwestern Medical Center in 2007. Dr. Magadan's Kansas license number on file is 04-35874.

Dr. Magadan's primary practice is Kansas City Physician Partners Inc, at 4440 Broadway Blvd, Kansas City, MO 64111 in Jackson County. The practice phone is (816) 531-0930.

Dr. Magadan's primary practice is Kansas City Physician Partners Inc in Kansas City, Missouri. Dr. Magadan is also affiliated with The University of Kansas Hospital. The medical group on file is Kansas City Physician Partners. Dmand AI also links Dr. Magadan to 4 more hospitals, 4 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Magadan practices, 9 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Magadan's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Magadan is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Magadan's licenses on file in 2 states: Kansas and Missouri.

Dmand AI lists arteritis, arthritis, fibromyalgia and chronic pain, fluid in a joint, gout, joint arthropathy, joint pain and lupus among the conditions Dr. Magadan treats.

CMS data shows 180,895 Medicare services from Dr. Magadan across 46 procedure codes in 2024, for 486 Medicare patients. Medicare paid $1,698,359 for them. Every service was in an office.

CMS counts 486 Medicare patients who saw Dr. Magadan in 2024. The largest group is 65 to 74, with 223 patients. 75% of them have arthritis, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Magadan's median patient age at 67, with 73% women.

In 2024, Dr. Magadan wrote 3,020 Medicare Part D claims for 462 patients. 90% of them were for generic drugs. CMS names the drug for 2,873 of them, across 36 drugs with 11 or more claims each, at $1,333,894 in total drug cost. In 2023, CMS named 2,491 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Magadan for performance year 2024, reported through an alternative payment model (APM). Dr. Magadan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Magadan as offering telehealth.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Magadan, published from 2017 to 2024. 2017 was the busiest year, with 2. Dr. Magadan has published most often in Kans J Med. Dr. Magadan's most frequent co-authors are Muhammad Aleem Imran, MD, Madhav V. Desai, MD, MPH and Satya Preetham Gunta, MD.

CMS Open Payments shows 121 general payments to Dr. Magadan from 18 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 58% of the total. Bristol-Myers Squibb Company paid the most, $2,923.

Dmand AI lists 2 awards for Dr. Magadan, most recently NCQA PCSP in 2017.

Dr. Magadan graduated from UT Southwestern Medical Center in 2007. Dr. Magadan is a member of ACR and ACR.

Dr. Magadan is in network with 15 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.